 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | |
|---|
|
|---|
4/5/21 Bristol-Myers Squibb Co. SC 13G/A 2:70K Jounce Therapeutics, Inc. Broadridge Fin’l So… Inc
Celgene Switzerland LLC³
| ____________ | | ¹ | Filing/Form Type: | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
